<DOC>
	<DOCNO>NCT03023774</DOCNO>
	<brief_summary>Evaluate effectiveness granulocyte colony-stimulating factor ( GCSF ) treatment thin endometrium woman recurrent implantation failure ICSI cycle</brief_summary>
	<brief_title>Use Gcsf Patients With Recurrent Ivf/Icsi Failure</brief_title>
	<detailed_description>Prospective analytical study conduct private IVF center start june 2016. study recruit fertility clinic center fulfil inclusion exclusion criterion , patient subject complete history take medical fertility history include previous induction implantation failure . patient randomize two group , group A treat neupogen 30 international unit ( IU ) group B treat clexane 40mg estrogen . study procedure : ovary stimulate standard protocol ( long GnRH Agonist ) gonadotrophic release hormone ( GnRH Antagonist , least 3 follicle achieve 18 mm diameter , Human chorionic gonadotrophic ( hCG ) ( 10000 IU ) administer ovulation triggering , transvaginal oocyte retrieval perform 36-38 hour injection hCG . oocytes fertilized intracytoplasmic sperm injection ( ICSI ) method . thickness endometrium evaluate day oocyte retrieval syringe containing ( 300 mcg/1 ml ) GCSF ( neupogen ) infuse slowly uterine cavity 5 day ( embryo transfer ) endometrial thickness evaluate . patient receive oral parenteral progesterone luteal phase support .</detailed_description>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>male partner normal semen analysis accord world health organization ( WHO ) 2010. female partner age 36 present : athin endometrium ( le 7 mm transvaginal ultrasound ) b previous history multiple unexplained female history Asherman 's syndrome , fibroid , polyp diagnostic hysteroscopy woman sickle cell disease , renal insufficiency , upper respiratory infection pneumonia , chronic neutropenia , know past present malignancy</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>36 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>